ARCHIVES

Eight States Get Cervical Cancer Screening Planning Contracts

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

May 18, 2007

NCI Advisory Group, Other Cancer Meetings

January 2, 1981

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

October 8, 1976